Opioid reduction in ambulatory thyroid and parathyroid surgery after implementing enhanced recovery after surgery protocol

Head Neck. 2021 May;43(5):1545-1552. doi: 10.1002/hed.26617. Epub 2021 Jan 27.

Abstract

Background: Opioid abuse is widespread in the United States and the risk for chronic use is increased in surgical patients, including patients with thyroid and parathyroid.

Methods: Records for 171 patients prior to and 67 patients following implementation of an enhanced recovery after surgery (ERAS) protocol for ambulatory thyroid/parathyroid surgeries were reviewed. The ERAS included superficial cervical plexus block, multimodal premedication, and postoperative reliance on acetaminophen and ibuprofen with judicious prescribing of opioids.

Results: Post-ERAS patients were prescribed a mean 72 morphine milligram equivalents (MME); pre-ERAS patients were prescribed a mean 163 MME (p < 0.001). 97.1% of pre-ERAS patients were prescribed opioids with 91.1% filled; 68.7% of post-ERAS study patients were prescribed opioids with 84.8% filled.

Conclusion: Implementation of ERAS and focus on prescribing practices decreased the MME prescribed and used for ambulatory thyroid and parathyroid surgery. Future steps include increased patient education and tracking pain scores and medication utilization out of hospital.

Keywords: early recovery after surgery; morphine milligram equivalents; multimodal; opioids; thyroid and parathyroid surgery.

MeSH terms

  • Analgesics, Opioid*
  • Enhanced Recovery After Surgery*
  • Humans
  • Pain Management
  • Pain, Postoperative / drug therapy
  • Pain, Postoperative / prevention & control
  • Retrospective Studies
  • Thyroid Gland / surgery

Substances

  • Analgesics, Opioid